Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 933 blog entries.

March 2026

OhioHealth Begins Building New Cancer Center in Columbus

2026-03-31T11:49:29+00:00

Construction of OhioHealth’s new cancer center at its administrative campus in Columbus is underway.OhioHealth started the project at 3430 OhioHealth Pkwy. this month, with the installation of construction fencing around the surface parking lot south of the campus, according to a community announcement.The new facility, which is expected to be completed in late 2028, will be located on the [...]

OhioHealth Begins Building New Cancer Center in Columbus2026-03-31T11:49:29+00:00

Global Diagnostic Labs Market to Grow at a CAGR of 6.66%, Reaching USD 223 Billion by 2032, Reports Vyansa Intelligence

2026-03-31T11:47:39+00:00

According to the market research study published by Vyansa Intelligence, the Global Diagnostic Labs Market is projected to grow at a CAGR of around 6.66% during 2026–2032. The market expansion is primarily driven by the increasing demand for early and accurate disease diagnosis, rising burden of chronic and infectious diseases, growing adoption of preventive healthcare practices, and [...]

Global Diagnostic Labs Market to Grow at a CAGR of 6.66%, Reaching USD 223 Billion by 2032, Reports Vyansa Intelligence2026-03-31T11:47:39+00:00

Development of an artificial intelligence-based computer-aided detection system for routine gastric biopsy diagnosis

2026-03-31T11:44:28+00:00

The following abstract is drawn from a recently published paper in Journal of Pathology Informatics. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Daiki Taniyamaa,b,d, Kazuya Kuraokac,d, Akihisa Saitoc,d, Aya Kidoc,d, [...]

Development of an artificial intelligence-based computer-aided detection system for routine gastric biopsy diagnosis2026-03-31T11:44:28+00:00

The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes

2026-03-30T08:59:54+00:00

Author: Roman Fabbricatore Specialized LLMs, AI-assisted CT scans for early detection, and foundational models democratizing pathology are among emerging technologies in oncology care. Artificial intelligence (AI) has been utilized in a variety of capacities to fundamentally transform oncology care since its inception. Technology that initially started out as a “hallucination-prone punch line” per Matthew [...]

The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes2026-03-30T08:59:54+00:00

Nottingham University Hospitals Goes Live with Cirdan’s ULTRA Laboratory Information System, Transforming Histopathology Services

2026-09-29T18:09:10+00:00

Nottingham University Hospitals NHS Trust (NUH) has successfully completed the go-live of Cirdan’s ULTRA Laboratory Information System (LIS) for Cellular Pathology services, achieved in November 2025. This followed the success of an earlier implementation at Sherwood Forest Hospitals for histopathology Services in April 2025. The NUH implementation spans two laboratory sites situated at Nottingham City Hospital [...]

Nottingham University Hospitals Goes Live with Cirdan’s ULTRA Laboratory Information System, Transforming Histopathology Services2026-09-29T18:09:10+00:00

Defining Hotspot for Estimation of Ki-67 Proliferation Index of Neuroendocrine Tumors: QuPath Algorithm vs. Manual Assessment

2026-03-27T10:31:21+00:00

The following abstract is drawn from a recently published paper in Journal of Pathology Informatics. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Ruben Oganesyana, Osman Yilmazb, Yevgen Chornenkyya, [...]

Defining Hotspot for Estimation of Ki-67 Proliferation Index of Neuroendocrine Tumors: QuPath Algorithm vs. Manual Assessment2026-03-27T10:31:21+00:00

Source BioScience Sharewear Charity Visit

2026-04-07T07:49:25+00:00

On 10th February, colleagues from Source BioScience volunteered with our sponsored charity, Sharewear, supporting their vital work providing free clothing to individuals and families in need. Based in Nottingham, Sharewear sorts and prepares donated clothing for clients who are referred to access essential items at no cost. During the visit, our colleagues were given a tour [...]

Source BioScience Sharewear Charity Visit2026-04-07T07:49:25+00:00

Discovery Life Sciences and Mindpeak Partner to Bring AI Precision to Cancer Biomarker Testing in Global Clinical Trials

2026-04-02T10:53:35+00:00

New alliance takes aim at inconsistent biomarker interpretation across pathologists, a persistent challenge in drug development Inconsistent biomarker interpretation across pathologists remains one of the more stubborn challenges in clinical trial development, contributing to variability in patient stratification and eroding confidence in critical go/no-go decisions. Discovery Life Sciences (Discovery), a provider of biospecimens and biomarker specialty [...]

Discovery Life Sciences and Mindpeak Partner to Bring AI Precision to Cancer Biomarker Testing in Global Clinical Trials2026-04-02T10:53:35+00:00

How Pathology Images Can Transform Patient Understanding and Care

2026-03-27T09:57:32+00:00

Pathology is a specialty that most patients never interact with directly—but what if they could? In this episode, I talk with Dr. Lija Joseph, a trailblazing pathologist who is challenging the status quo by bringing patients into the pathology process. She shares how showing patients their own biopsy slides is empowering them to better understand their disease, make more informed decisions, and [...]

How Pathology Images Can Transform Patient Understanding and Care2026-03-27T09:57:32+00:00

Lumea Partners with Primaa to Expand Dermatopathology Offerings with Cleo Skin AI

2026-04-02T08:24:05+00:00

By Abigail Diepeveen Lumea, the U.S. leader in primary clinical digital pathology, today announced a partnership with Primaa, a leading provider of integrated AI solutions for dermatopathology and breast pathology, that significantly expands its diagnostic ecosystem for dermatology groups everywhere. Lumea’s IMS Viewer+ (FDA-cleared and CE-marked under IVDR) now seamlessly incorporates Cleo Skin, Primaa’s flagship AI [...]

Lumea Partners with Primaa to Expand Dermatopathology Offerings with Cleo Skin AI2026-04-02T08:24:05+00:00
Go to Top